Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management will deliver a presentation on Wednesday, January 15th at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time).
Investors and interested parties can access both the live presentation and archived webcast through Absci's investor relations website at investors.absci.com.
Absci (Nasdaq: ABSI), un'azienda che utilizza l'IA generativa orientata ai dati per la creazione di farmaci, ha annunciato la sua partecipazione al 43° Annual J.P. Morgan Healthcare Conference a San Francisco. La direzione dell'azienda presenterà un intervento mercoledì 15 gennaio alle 16:30, ora del Pacifico (19:30, ora orientale).
Gli investitori e le parti interessate possono accedere sia alla presentazione in diretta che al webcast archiviato tramite il sito web delle relazioni con gli investitori di Absci all'indirizzo investors.absci.com.
Absci (Nasdaq: ABSI), una empresa de creación de fármacos basada en IA generativa orientada a los datos, ha anunciado su participación en la 43ª Conferencia Anual de Salud de J.P. Morgan en San Francisco. La gestión de la empresa realizará una presentación el miércoles 15 de enero a las 4:30 p.m., hora del Pacífico (7:30 p.m., hora del Este).
Los inversores y partes interesadas pueden acceder tanto a la presentación en vivo como a la grabación a través del sitio web de relaciones con inversores de Absci en investors.absci.com.
Absci (Nasdaq: ABSI), 데이터 중심의 생성적 AI를 활용한 의약품 개발 회사가 샌프란시스코에서 열리는 제43회 연례 J.P. 모건 헬스케어 콘퍼런스에 참여한다고 발표했습니다. 회사 경영진은 1월 15일 수요일 오후 4시 30분 (태평양 시간) (동부 시간으로 오후 7시 30분)에 발표를 진행할 예정입니다.
투자자 및 관심 있는 당사자는 Absci의 투자자 관계 웹사이트인 investors.absci.com을 통해 실시간 발표와 보관된 웹캐스트에 접근할 수 있습니다.
Absci (Nasdaq: ABSI), une entreprise de création de médicaments basée sur l'IA générative axée sur les données, a annoncé sa participation à la 43e Conférence annuelle J.P. Morgan Healthcare à San Francisco. La direction de l'entreprise présentera une intervention le mercredi 15 janvier à 16h30, heure du Pacifique (19h30, heure de l'Est).
Les investisseurs et les parties intéressées peuvent accéder à la fois à la présentation en direct et à l'archive de la webdiffusion via le site web des relations investisseurs d'Absci à l'adresse investors.absci.com.
Absci (Nasdaq: ABSI), ein datengestütztes Unternehmen zur generativen KI für die Medikamentenentwicklung, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare Conference in San Francisco bekannt gegeben. Das Management des Unternehmens wird eine Präsentation am Mittwoch, den 15. Januar um 16:30 Uhr pazifischer Zeit (19:30 Uhr östlicher Zeit) halten.
Investoren und Interessierte können sowohl auf die Live-Präsentation als auch auf das archivierte Webcast über die Investoren-Website von Absci unter investors.absci.com zugreifen.
- None.
- None.
VANCOUVER, Wash. and NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Absci management is scheduled to present on Wednesday, January 15th at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company’s investor relations website at: investors.absci.com.
About Absci
Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.
Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com
Media Contact
press@absci.com
FAQ
When is Absci (ABSI) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Absci's (ABSI) J.P. Morgan Healthcare Conference presentation?
Which healthcare conference is Absci (ABSI) participating in January 2025?
What type of company is Absci (ABSI) described as in their conference announcement?
